Loading resource…

JAMA
Rheumatoid arthritis affects approximately 0.53% of adults globally and is more prevalent in females than males. The review discusses the clinical presentation, including joint and extra-articular manifestations, and highlights the importance of early diagnosis and treatment. It also covers the risks associated with various treatment options, including biological DMARDs and JAK inhibitors, and emphasizes the need for preventive measures against infections during therapy.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

Repurposing leflunomide and hydroxychloroquine to treat Sjögren's disease (RepurpSS-II): a randomised, double-blind, placebo-controlled, phase 2b trial
Same clinical topic · Rheumatology

EARLY TRAUMA AS THE ORIGIN OF CHRONIC INFLAMMATION: A PSYCHONEUROIMMUNOLOGICAL PERSPECTIVE
Same clinical topic · Rheumatology

IDIOPATHIC INFLAMMATORY MYOPATHIES
Same clinical topic · Rheumatology

MULTIFACTORIAL PATHOGENESIS OF RHEUMATOID ARTHRITIS
Same clinical topic · Rheumatology

SYSTEMIC LUPUS ERYTHEMATOSUS IN CRITICAL CARE: A SYSTEMATIC REVIEW OF ICU OUTCOMES AND MANAGEMENT
Same clinical topic · Rheumatology

RHEUMATOID ARTHRITIS — COMMON ORIGINS, DIVERGENT MECHANISMS
Same clinical topic · Rheumatology

BIOLOGICAL THERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Same clinical topic · Rheumatology

SYSTEMIC LUPUS ERYTHEMATOSUS: DIAGNOSIS AND TREATMENT
Same clinical topic · Rheumatology

SYSTEMIC LUPUS ERYTHEMATOSUS: NEW DIAGNOSTIC AND THERAPEUTIC APPROACHES
Same clinical topic · Rheumatology